- Home
- IXHL
as 11-15-2024 4:00pm EST
Stocks
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
| Founded: | 2001 | Country: | Australia |
| Employees: | N/A | City: | DOCKLANDS, VICTORIA |
| Market Cap: | 39.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 43.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.80 - $12.68 | Next Earning Date: | 09-30-2024 |
| Revenue: | $86,000 | Revenue Growth: | -86.86% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Incannex Healthcare Inc. News
IXHL Breaking Stock News: Dive into IXHL Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
24 days ago
Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer
Simply Wall St.
a month ago
Incannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable Picks
Newsfile
a month ago
Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)
GlobeNewswire
2 months ago
Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates
GlobeNewswire
2 months ago
Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors
Newsfile
2 months ago
Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives
GlobeNewswire
3 months ago
FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed
Compare IXHL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IXHL Incannex Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.